June 12, 2024
Retired: Osteogenesis Stimulators Added to Required Prior Authorization
On May 13, 2024, CMS announced updates to the Master List and the Required Face-to-Face Encounter and Required Written Order Prior to Delivery (WOPD) List
.
CMS selected osteogenesis stimulator HCPCS codes E0747, E0748, E0760 that will require prior authorization. There will be two phases of implementation:
- Phase one begins August 12, 2024, in California, Florida, Ohio, and Pennsylvania.
- Phase two begins November 12, 2024, in all remaining states and territories not included in phase 1.
Learn more about these requirements in MLN Matters Article SE20007
.
We will publish more information and education soon.
Publication History
| July 30, 2025 | Retired due to CMS suspending prior authorization for osteogenesis stimulators, effective August 28, 2024. |
| June 12, 2024 | Originally Published |

